ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $451,000 | +2.3% | 210,000 | +50.0% | 0.17% | +5.0% |
| Q1 2017 | $441,000 | -29.3% | 140,000 | -41.7% | 0.16% | -29.1% |
| Q4 2016 | $624,000 | -19.8% | 240,000 | +20.0% | 0.23% | -22.0% |
| Q3 2016 | $778,000 | +122.9% | 200,000 | +53.8% | 0.29% | +117.2% |
| Q2 2016 | $349,000 | +642.6% | 130,000 | +738.7% | 0.13% | +605.3% |
| Q1 2016 | $47,000 | -46.0% | 15,500 | -3.1% | 0.02% | -38.7% |
| Q3 2014 | $87,000 | – | 16,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |